Status: Recruiting
Clinical Trials of Quadrivalent Influenza Vaccine
This clinical trial adopts a seamless design of phase I/II, conducted in two stages: phase I and phase II. Phase I is the age/dose ramp up stage, and phase II is the dose expansion stage.The purpose of this clinical trial is to evaluate the safety and tolerability of different doses of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant，explore the immunogenicity of the vaccine, and determine the appropriate dose for later clinical trials of this product.
Participants needed: 620
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Updated: May 5, 2026Locations: 1
Eligibility criteria
When signing the informed consent form, be at least 18 years old and provide val... [+3]
The laboratory test indicators specified in the protocol are abnormal and clinic... [+18]